RxDoctor Payments Data

Rukshana Cader, MD

Gastroenterology · Prescott, AZNPI 1295943660

Payments from drug & device makers

$3,416in general payments, 2019–2025

Across 149 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Gilead$488
  • Madrigal Pharmaceuticals$241
  • Takeda Pharmaceuticals U.S.A., Inc.$227
  • Sanofi$162
  • Merck$151
  • plus $773 from 12 others

What the payments were for

  • Food & beverage$3,416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,416 in reported general payments places this provider in the 40th percentile of 355 gastroenterology providers in Arizona.

See all gastroenterology providers in Arizona

Medicare billing

Part B allowed, 2024
$56,758
Medicare patients
235
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide31$23,168
Dexlansoprazole DrDexlansoprazole29$6,669
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates76$4,978
Sucralfate19$1,606
Pantoprazole Sodium123$1,500
Lubiprostone11$1,326
Omeprazole71$821
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg19$495
Esomeprazole Magnesium19$461
Famotidine19$336
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine17$329
Lactulose12$238
Ondansetron OdtOndansetron12$150

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,373$23,16831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 355 gastroenterology providers in Arizona.

Other gastroenterology in Prescott

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →